Xiaotong Cao

Statistics

Publications

Citations

170

H-Index

Active since

2020

Affiliations

Shenyang Pharmaceutical University(Current)

Harvard University

McLean Hospital

Xiaotong Cao is an author at Shenyang Pharmaceutical University specializing in pharmacology, biochemical pharmacology, and benign prostatic hyperplasia.

Publications per year

2020–2021

Publications

Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS

Linlin Xie, David Yue-Wei Lee, Ying Shang et al. · Phytomedicine · 2020 · 71 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Screening for natural inhibitors of 5-lipoxygenase from Zi-shen pill extract by affinity ultrafiltration coupled with ultra performance liquid chromatography-mass spectrometry

Siqi Wang, Jiaxin Huai, Ying Shang et al. · Journal of Ethnopharmacology · 2020 · 35 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Flavonoids derived from Anemarrhenae Rhizoma ameliorate inflammation of benign prostatic hyperplasia via modulating COX/LOX pathways

Xiaotong Cao, Ying Shang, Weigui Kong et al. · Journal of Ethnopharmacology · 2021 · 35 citations

Medicine, Pharmacology, Urology +12

The bioactive alkaloids identified from Cortex Phellodendri ameliorate benign prostatic hyperplasia via LOX-5/COX-2 pathways

Siqi Wang, David Yue-Wei Lee, Ying Shang et al. · Phytomedicine · 2021 · 29 citations

Medicine, Pharmacology, Urology +7

1–4 of 4